About PhenoVista
PhenoVista is a company based in San Diego (United States) founded in 2014 was acquired by InSphero in May 2026. PhenoVista has raised $3 million across 4 funding rounds from investors including Fujifilm, InSphero and HHS. PhenoVista offers products and services including Custom Services, Ready-2-Go Assays, Cell Painting & Screening, and Imaging & Analysis. PhenoVista operates in a competitive market with competitors including Reaction Biology, ImmunoSCAPE, Discovery Biomed, BCI Pharma and ICE Bioscience, among others.
- Headquarter San Diego, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Phenovista Biosciences
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of PhenoVista
PhenoVista offers a comprehensive portfolio of products and services, including Custom Services, Ready-2-Go Assays, Cell Painting & Screening, and Imaging & Analysis.
Tailored assays for specific drug discovery needs
Off-the-shelf solutions for immediate research use
Techniques for visualizing and screening cellular responses
Advanced imaging to provide quantitative biological insights
People of PhenoVista
Unlock access to complete
Funding Insights of PhenoVista
PhenoVista has successfully raised a total of $3M across 4 strategic funding rounds. The most recent funding activity was a Seed round of $3 million completed in January 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in PhenoVista
PhenoVista has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include Fujifilm, InSphero and HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multiple sectors are invested in by the venture capital firm.
|
Locked | Locked | Locked | |
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked | |
|
Cell-based assays and 3D microtissues for drug screening are developed.
|
Locked | Locked | Locked |
Investor details for PhenoVista
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by PhenoVista
Investment portfolio details for PhenoVista
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - PhenoVista
Detailed financials for PhenoVista
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Phenovista Comparisons
Peer comparison for PhenoVista
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of PhenoVista
PhenoVista operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Reaction Biology, ImmunoSCAPE, Discovery Biomed, BCI Pharma and ICE Bioscience, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
In vitro enzyme activity assays, secializing in kinase & epigenetic HTS and profiling
|
|
| Locked | Locked | Locked |
High-dimensional immune profiling services are delivered via proprietary platform.
|
|
| Locked | Locked | Locked |
Custom human cell engineering and drug discovery services are provided.
|
|
| Locked | Locked | Locked |
Contract research services in cancer and neuroinflammation are offered.
|
|
| Locked | Locked | Locked |
Specialised CRO offering a range of screening platforms for cardiac safety testing, ion channel profiling and in vitro HTS screening
|
Detailed competitors of PhenoVista
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Phenovista
Complete news archive for PhenoVista
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PhenoVista
PhenoVista was founded in 2014 and raised its 1st funding round 3 years after it was founded.
PhenoVista is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
PhenoVista is a funded company, having raised a total of $3M across 4 funding rounds to date.
PhenoVista was founded in 2014 and is based in San Diego, United States. Operations are centered in the biotechnology sector as a contract research organization. Services encompass phenotypic assay development and high-throughput screening, with emphasis on functional neuronal assays utilizing iPS-derived neurons, embryonic stem cell differentiation, human inflammation models, and myotube formation processes. These capabilities support drug discovery efforts in neuroscience and related fields.
PhenoVista's top competitors include ImmunoSCAPE, Quantumcyte and Reaction Biology.
PhenoVista offers Custom Services, Ready-2-Go Assays, Cell Painting & Screening, and Imaging & Analysis.